Antisoma to present at Canaccord Global Growth Conference

6 August 2010, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that senior executive Dr Michael Boss will present at the 30th Annual Canaccord Global Growth Conference in Boston on Wednesday August 11 at 1pm local time (6pm BST). A webcast of the presentation will be available on Antisoma's website at For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software. Enquiries: Alison Saville Senior Marketing and Communications Executive Antisoma plc +44 (0)20 3249 2100 Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please for further information about Antisoma. [HUG#1436343] This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction for further distribution is prohibited. Source: Antisoma plc via Thomson Reuters ONE